ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2019

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus.

Jing Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.